Cell Permeable Nanobodies for Intracellular Antigens

Monoclonal antibodies work well for extracellular or cell surface-bound target antigens. Inside the membrane, though, small molecules with favorable pharmacological properties (e.g., Lipinski’s Rule of 5) are preferred.

That paradigm could change thanks to smaller antibodies (“nanobodies”) conjugated to cell penetrating peptides, as shown by Herce et al. (2017) in “Cell-permeable nanobodies for targeted immunolabelling and antigen manipulation in living cells.”

Coupled with new, well-named methods like AdPROM (Affinity-directed Protein Missiles) that mediate the “orderly” proteasomal degradation of targets, we may be opening a new chapter in pharmacology.

Also see: Phys.com, “Researchers report on cell-permeable nanobodies” 2017.

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s